top of page

SUBSCRIBE TO OUR NEWSLETTER

THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

Search

PHERGain-2: Approved in 5 countries

PHERGain-2: Approved in 5 countries

PHERGain-2: Approved in 5 countries

CANCER RESEARCH

Apr 21, 20221 min read

265 views

HER2 Breast Cancer: Types and Treatments

HER2 Breast Cancer: Types and Treatments

HER2 Breast Cancer: Types and Treatments

LIVING WITH CANCER

Feb 16, 20223 min read

128 views

Spotlight: PHERGain-2 HER2+ early breast cancer trial

Spotlight: PHERGain-2 HER2+ early breast cancer trial

Spotlight: PHERGain-2 HER2+ early breast cancer trial

CANCER RESEARCH

Nov 23, 20212 min read

794 views

Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer

Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer

Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer

CANCER RESEARCH

Oct 18, 20218 min read

166 views

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer

CANCER RESEARCH

Oct 12, 20213 min read

318 views

DEBBRAH Study (breast)

DEBBRAH Study (breast)

DEBBRAH Study (breast)

Jun 1, 20211 min read

69 views

PHERGain Study (breast)

PHERGain Study (breast)

PHERGain Study (breast)

May 4, 20211 min read

81 views

bottom of page